Phase 1, Open-label, Randomized Crossover Study in Healthy Adult Subjects to Assess the Relative Oral Bioavailability and Food Effect of Bedaquiline 100-mg Tablets Administered as Different Test Formulations Compared to the Commercial Tablet Formulation (F001)
Latest Information Update: 27 Jan 2020
At a glance
- Drugs Bedaquiline (Primary)
- Indications Leprosy; Tuberculosis
- Focus Pharmacokinetics
- Sponsors Janssen Research & Development
- 21 Jan 2020 Status changed from active, no longer recruiting to completed.
- 04 Nov 2019 Status changed from recruiting to active, no longer recruiting.
- 11 Oct 2019 Status changed from not yet recruiting to recruiting.